27 October 2009 - Microbix has signed an agreement with the Hunan Biopharmaceutical Company for initial financing to construct Asia's largest influenza vaccine production facility.
The facility will have the capacity to produce more than 100 million doses of seasonal influenza vaccine annually and up to 300 million doses of a pandemic influenza vaccine in the event of an outbreak to immunise against a single strain of influenza.
